Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma

Clinical trial NCT07758673 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07758673
Sponsor: City of Hope Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent B Acute Lymphoblastic Leukemia Recurrent B Lymphoblastic Lymphoma Refractory B Acute Lymphoblastic Leukemia Refractory B Lymphoblastic Lymphoma

Start date: 2027-04-17
Primary completion: 2028-07-26
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.